Molecular diagnostics and potential therapeutic options for mycobacterium tuberculosis: Where we stand
Authors:
- Zafran KhanZKZafran Khan
- Daniya UaliyevaDUDaniya Ualiyeva
- Khalid JamalKJKhalid Jamal
- Babar AliBABabar Ali
- Fayaz AhmadFAFayaz Ahmad
- Sanjeep SapkotaSSSanjeep Sapkota
- Obed Boadi AmissahOAObed Boadi Amissah
- Petuel Ndip Ndip BatePBPetuel Ndip Ndip Bate
Open Access
- 5 May 2023
- journal article
- review article
- Published by Elsevier in Medicine in Omics
- Vol. 8
Abstract
No abstract availableThis publication has 122 references indexed in Scilit:
- MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and CorynebacteriaChemistry & Biology, 2012
- Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone OxidoreductaseJournal of Biological Chemistry, 2011
- Chemical modification of capuramycins to enhance antibacterial activityJournal of Antimicrobial Chemotherapy, 2010
- Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrBAntimicrobial Agents and Chemotherapy, 2009
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO ReleaseScience, 2008
- Antimicrobial Activity of DC-159a, a New Fluoroquinolone, against 1,149 Recently Collected Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2008
- Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636Microbiology, 2008
- Molecular Insights into the Biosynthesis of the F420 CoenzymeJournal of Biological Chemistry, 2008
- Moxifloxacin Lethality against Mycobacterium tuberculosis in the Presence and Absence of ChloramphenicolAntimicrobial Agents and Chemotherapy, 2006
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998